219 related articles for article (PubMed ID: 16412675)
21. Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation.
Flusser H; Korman SH; Sato K; Matsubara Y; Galil A; Kure S
Neurology; 2005 Apr; 64(8):1426-30. PubMed ID: 15851735
[TBL] [Abstract][Full Text] [Related]
22. Arginine 302 mutations in the pyruvate dehydrogenase E1alpha subunit gene: identification of further patients and in vitro demonstration of pathogenicity.
Otero LJ; Brown RM; Brown GK
Hum Mutat; 1998; 12(2):114-21. PubMed ID: 9671272
[TBL] [Abstract][Full Text] [Related]
23. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
24. Mutational study in the PDHA1 gene of 40 patients suspected of pyruvate dehydrogenase complex deficiency.
Quintana E; Gort L; Busquets C; Navarro-Sastre A; Lissens W; Moliner S; Lluch M; Vilaseca MA; De Meirleir L; Ribes A; Briones P;
Clin Genet; 2010 May; 77(5):474-82. PubMed ID: 20002461
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis of very long chain acyl-CoA dehydrogenase deficiency in three Israeli patients: identification of a complex mutant allele with P65L and K247Q mutations, the former being an exonic mutation causing exon 3 skipping.
Watanabe H; Orii KE; Fukao T; Song XQ; Aoyama T; IJlst L; Ruiter J; Wanders RJ; Kondo N
Hum Mutat; 2000; 15(5):430-8. PubMed ID: 10790204
[TBL] [Abstract][Full Text] [Related]
26. First characterization of a large deletion of the PDHA 1 gene.
Brivet M; Moutard ML; Zater M; Venet L; Chenel C; Mine M; Legrand A
Mol Genet Metab; 2005 Dec; 86(4):456-61. PubMed ID: 16256390
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the E1beta subunit gene (PDHB) in four families with pyruvate dehydrogenase deficiency.
Okajima K; Korotchkina LG; Prasad C; Rupar T; Phillips JA; Ficicioglu C; Hertecant J; Patel MS; Kerr DS
Mol Genet Metab; 2008 Apr; 93(4):371-80. PubMed ID: 18164639
[TBL] [Abstract][Full Text] [Related]
28. One novel and one recurrent mutation in the PROS1 gene cause type I protein S deficiency in patients with pulmonary embolism associated with deep vein thrombosis.
Mizukami K; Nakabayashi T; Naitoh S; Takeda M; Tarumi T; Mizoguchi I; Ieko M; Koike T
Am J Hematol; 2006 Oct; 81(10):787-97. PubMed ID: 16868938
[TBL] [Abstract][Full Text] [Related]
29. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
Anderson RA; Bryson GM; Parks JS
Mol Genet Metab; 1999 Nov; 68(3):333-45. PubMed ID: 10562460
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH.
Duponchel C; Djenouhat K; Frémeaux-Bacchi V; Monnier N; Drouet C; Tosi M
Hum Mutat; 2006 Mar; 27(3):295-6. PubMed ID: 16470590
[TBL] [Abstract][Full Text] [Related]
31. Carnitine/acylcarnitine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family.
Yang BZ; Mallory JM; Roe DS; Brivet M; Strobel GD; Jones KM; Ding JH; Roe CR
Mol Genet Metab; 2001 May; 73(1):64-70. PubMed ID: 11350184
[TBL] [Abstract][Full Text] [Related]
32. A novel mutation (c.951C>T) in an exonic splicing enhancer results in exon 10 skipping in the human mitochondrial acetoacetyl-CoA thiolase gene.
Fukao T; Horikawa R; Naiki Y; Tanaka T; Takayanagi M; Yamaguchi S; Kondo N
Mol Genet Metab; 2010 Aug; 100(4):339-44. PubMed ID: 20488739
[TBL] [Abstract][Full Text] [Related]
33. A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney.
Shao L; Liu L; Miao Z; Ren H; Wang W; Lang Y; Yue S; Chen N
Am J Nephrol; 2008; 28(6):900-7. PubMed ID: 18580052
[TBL] [Abstract][Full Text] [Related]
34. [Exon 5 alternative splicing of the cytochrome P450 aromatase could be a regulatory mechanism for estrogen production in humans].
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Berensztein E; Rivarola MA; Belgorosky A
Medicina (B Aires); 2007; 67(4):369-73. PubMed ID: 17891933
[TBL] [Abstract][Full Text] [Related]
35. Splice variants but not mutations of DNA polymerase beta are common in bladder cancer.
Thompson TE; Rogan PK; Risinger JI; Taylor JA
Cancer Res; 2002 Jun; 62(11):3251-6. PubMed ID: 12036941
[TBL] [Abstract][Full Text] [Related]
36. A 1.1 million base pair X-chromosomal deletion covering the PDHA1 and CDKL5 genes in a female patient with West syndrome and pyruvate oxidation deficiency.
Mayr JA; Koch J; Fauth C; Zimmermann FA; Rauscher C; Zschocke J; Sperl W
Neuropediatrics; 2012 Jun; 43(3):130-4. PubMed ID: 22473288
[TBL] [Abstract][Full Text] [Related]
37. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
38. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
39. Splice-site mutation c.313+1, G>A in intron 3 of the LDL receptor gene results in transcripts with skipping of exon 3 and inclusion of intron 3.
Cameron J; Holla ØL; Kulseth MA; Leren TP; Berge KE
Clin Chim Acta; 2009 May; 403(1-2):131-5. PubMed ID: 19361455
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterisation of Tyr530Ser and IVS16-1G>T mutations causing severe factor V deficiency.
Zheng W; Liu Y; Luo Y; Chen Z; Wang Y; Zhang L; Gao G; Yao Z
Thromb Haemost; 2010 Sep; 104(3):536-43. PubMed ID: 20664902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
